Kirn David — SEC insider filings
SEC reporting owner CIK 1834021. 23 insider filings on record with FilingPulse; latest filed 2026-10-07.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2021-03-10 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 30 legs across 16 filings — 766,700 shares, $13,280,081 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 92,001 shares @ $27.13 ($2,495,822) in 4D Molecular Therapeutics, Inc., filed 2024-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | See Remarks, Director | 23 | — | 30 legs · 766,700 sh · $13,280,081 | 16 |
Insider filings — Kirn David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-07 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 58,061 @ $12.92 · Sale (S): 272 @ $13.61 | EDGAR |
| 2026-09-16 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 58,333 @ $13.90 | EDGAR |
| 2026-08-21 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 50,000 @ $4.14 · Sale (S): 43,149 @ $15.36 · Sale (S): 25,927 @ $16.42 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 26,842 @ $10.23 | EDGAR |
| 2026-08-04 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 12,415 @ $10.05 | EDGAR |
| 2026-07-14 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 42,608 @ $12.87 · Sale (S): 15,283 @ $12.01 · Sale (S): 442 @ $12.84 | EDGAR |
| 2026-06-23 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 114,746 @ $10.47 | EDGAR |
| 2026-06-02 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 1,922 @ $10.02 | EDGAR |
| 2026-03-27 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 267,500 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 11,653 @ $14.42 · Option exercise (M): 1,270 @ $15.78 · Sale (S): 12,923 @ $22.49 · Option exercise (M): 11,653 (derivative) @ $0 · Option exercise (M): 1,270 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 12,930 @ $14.42 · Sale (S): 12,930 @ $23.10 · Option exercise (M): 12,930 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 92,001 @ $27.13 | EDGAR |
| 2024-01-25 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 5,696 @ $18.41 | EDGAR |
| 2024-01-08 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 28,632 @ $17.27 · Sale (S): 4,702 @ $18.13 · Sale (S): 40,732 @ $20.31 · Sale (S): 28,104 @ $19.56 · Sale (S): 133 @ $20.11 | EDGAR |
| 2023-12-13 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 590,000 (derivative) @ $0 | EDGAR |
| 2023-05-04 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Gift (G): 600,000 @ $0 · Gift (G): 600,000 @ $0 | EDGAR |
| 2023-02-23 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 17,090 @ $20.93 · Sale (S): 907 @ $21.49 · Sale (S): 16,449 @ $20.22 | EDGAR |
| 2023-02-14 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 222,000 (derivative) @ $0 | EDGAR |
| 2023-01-23 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 10,899 @ $20.03 · Sale (S): 8,625 @ $20.19 | EDGAR |
| 2022-12-19 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 31,433 @ $23.56 · Sale (S): 1,500 @ $24.13 · Sale (S): 27,595 @ $22.66 · Sale (S): 26,349 @ $23.39 | EDGAR |
| 2022-02-03 | 4 | 4D Molecular Therapeutics Inc. (FDMT) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | 4D Molecular Therapeutics Inc. (FDMT) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834021 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs